{"entity":{"type":"insider","cik":"0001702283","url":"/insider/0001702283","json_url":"/insider/0001702283.json","name":"YANG MICHAEL J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2019-10-17","last":"2024-08-14","span_basis":"filed_date"},"name_variants":[{"name":"YANG MICHAEL J.","source":"filing","n_filings":8,"first_seen":"2019-10-17","last_seen":"2024-08-14"}],"transactions":[{"id":2154660,"accession":"0001396814-24-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001396814-24-000114","line_url":"/filing/0001396814-24-000114#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":12.9,"price_display":"12.90","price_state":"stated","total_value":25800.0,"total_display":"25,800.00","total_whole":"25,800","shares_owned_after":7230.0,"shares_owned_after_display":"7,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider"},{"id":5465266,"accession":"0001209191-21-002836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002836","line_url":"/filing/0001209191-21-002836#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1120.0,"shares_display":"1,120","price_per_share":53.34,"price_display":"53.34","price_state":"stated","total_value":59740.8,"total_display":"59,740.80","total_whole":"59,741","shares_owned_after":8059.0,"shares_owned_after_display":"8,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider"},{"id":2690112,"accession":"0001209191-20-055317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055317","line_url":"/filing/0001209191-20-055317#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1247.0,"shares_display":"1,247","price_per_share":42.56,"price_display":"42.56","price_state":"stated","total_value":53072.32,"total_display":"53,072.32","total_whole":"53,072","shares_owned_after":6457.0,"shares_owned_after_display":"6,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-19","scope":"insider"},{"id":2511162,"accession":"0001209191-20-042022","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042022","line_url":"/filing/0001209191-20-042022","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27250.0,"shares_display":"27,250","price_per_share":56.249040917431195,"price_display":"56.25","price_state":"stated","total_value":1532786.365,"total_display":"1,532,786.36","total_whole":"1,532,786","shares_owned_after":16304.0,"shares_owned_after_display":"16,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider","n_lines":2},{"id":2139826,"accession":"0001209191-20-026618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-026618","line_url":"/filing/0001209191-20-026618#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1501.0,"shares_display":"1,501","price_per_share":49.21,"price_display":"49.21","price_state":"stated","total_value":73864.21,"total_display":"73,864.21","total_whole":"73,864","shares_owned_after":5204.0,"shares_owned_after_display":"5,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-01","scope":"insider"},{"id":7790785,"accession":"0001209191-19-060476","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-060476","line_url":"/filing/0001209191-19-060476","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105479.0,"shares_display":"105,479","price_per_share":44.45683871671138,"price_display":"44.46","price_state":"stated","total_value":4689262.891,"total_display":"4,689,262.89","total_whole":"4,689,263","shares_owned_after":7531.0,"shares_owned_after_display":"7,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-13","scope":"insider","n_lines":2},{"id":8030112,"accession":"0001209191-19-060101","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-060101","line_url":"/filing/0001209191-19-060101","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14521.0,"shares_display":"14,521","price_per_share":50.464311080504096,"price_display":"50.46","price_state":"stated","total_value":732792.2612,"total_display":"732,792.26","total_whole":"732,792","shares_owned_after":5125.0,"shares_owned_after_display":"5,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":8299611,"accession":"0001209191-19-053493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053493","line_url":"/filing/0001209191-19-053493#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001702283","owner_name":"YANG MICHAEL J.","owner_display_name":"YANG MICHAEL J.","owner_url":"/insider/0001702283","role":"Officer (EVP and CCO)","role_mark":"O","role_mark_label":"Officer (EVP and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":877.0,"shares_display":"877","price_per_share":39.65,"price_display":"39.65","price_state":"stated","total_value":34773.05,"total_display":"34,773.05","total_whole":"34,773","shares_owned_after":1623.0,"shares_owned_after_display":"1,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Director","n_filings":1,"first_seen":"2024-08-14","last_seen":"2024-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP and CCO)","n_filings":7,"first_seen":"2019-10-17","last_seen":"2021-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001702283","retrieved_at":"2026-08-25T17:39:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}